Search Results - "Vieitez, J."

The pharmacokinetics and metabolism of ivermectin in domestic animal species by González Canga, Aránzazu, Sahagún Prieto, Ana M., José Diez Liébana, M., Martínez, Nélida Fernández, Vega, Matilde Sierra, Vieitez, Juan J. García

“…The pharmacokinetic properties of drugs are closely related to their pharmacological efficacy. The kinetics of ivermectin are characterised, in general terms,…”
Get full text

The Pharmacokinetics and Interactions of Ivermectin in Humans—A Mini-review by González Canga, Aránzazu, Sahagún Prieto, Ana M., Diez Liébana, M. José, Fernández Martínez, Nélida, Sierra Vega, Matilde, García Vieitez, Juan J.

“…Ivermectin is an antiparasitic drug with a broad spectrum of activity, high efficacy as well as a wide margin of safety. Since 1987, this compound has a…”
Get full text

Biological impacts of oil pollution and cleaning in the intertidal zone of exposed sandy beaches: Preliminary study of the “Prestige” oil spill by de la Huz, R., Lastra, M., Junoy, J., Castellanos, C., Viéitez, J.M.

“…On 13th September 2002, the oil tanker “Prestige” sunk off the Galician coast, causing one of the most important oil spills in history, which affected the…”
Get full text

Epidermal growth factor receptor activating mutations in Spanish gefitinib-treated non-small-cell lung cancer patients by Cortes-Funes, H., Gomez, C., Rosell, R., Valero, P., Garcia-Giron, C., Velasco, A., Izquierdo, A., Diz, P., Camps, C., Castellanos, D., Alberola, V., Cardenal, F., Gonzalez-Larriba, J. L., Vieitez, J. M., Maeztu, I., Sanchez, J. J., Queralt, C., Mayo, C., Mendez, P., Moran, T., Taron, M.

“…Background:: North American and Japanese non-small-cell lung cancer (NSCLC) patients with epidermal growth factor receptor (EGFR) activation via tyrosine…”
Get full text

Enrofloxacin: pharmacokinetics and metabolism in domestic animal species by López-Cadenas, Cristina, Sierra-Vega, Matilde, García-Vieitez, Juan J, Diez-Liébana, M José, Sahagún-Prieto, Ana, Fernández-Martínez, Nélida

“…Enrofloxacin is a fluorquinolone exclusively developed for use in veterinary medicine (1980). The kinetics of enrofloxacin are characterized, in general terms,…”
Get more information

Oral Capecitabine Compared With Intravenous Fluorouracil Plus Leucovorin in Patients With Metastatic Colorectal Cancer: Results of a Large Phase III Study by VAN CUTSEM, Eric, TWELVES, Chris, MCKENDRICK, Joe, OSTERWALDER, Bruno, PEREZ-MANGA, Gumersindo, ROSSO, Riccardo, ROUGIER, Philippe, SCHMIEGEL, Wolff H, SEITZ, Jean-Francois, THOMPSON, Paul, VIEITEZ, Jose Maria, HARPER, Peter, CASSIDY, Jim, WEITZEL, Christof, ALLMAN, David, BAJETTA, Emilio, BOYER, Michael, BUGAT, Roland, FINDLAY, Mike, FRINGS, Stefan, JAHN, Michaela

“…To compare the efficacy and safety of orally administered capecitabine (Xeloda; Roche Laboratories, Inc, Nutley, NJ), a novel fluoropyrimidine carbamate…”
Get full text

Results of REARRANGE trial: A randomized phase 2 study comparing different dosing approaches for regorafenib (REG) during the first cycle of treatment in patients (pts) with metastatic colorectal cancer (mCRC) by Argiles, G., Margalef, N. Mulet, Valladares-Ayerbes, M., de Prado, J. Vieitez, Grávalos, C., Alfonso, P. García, Santos, C., Tobeña, M., Sastre, J., Benavides, M., Cano, T., Loupakis, F., Garrote, M. Rodriguez, Rivera, F., Goldberg, R., Falcone, A., Bennouna, J., Ciardiello, F., Tabernero, J., Aranda, E.

Get full text

SEOM clinical guidelines for diagnosis and treatment of metastatic colorectal cancer 2015 by Aranda, E., Aparicio, J., Alonso, V., Garcia-Albeniz, X., Garcia-Alfonso, P., Salazar, R., Valladares, M., Vera, R., Vieitez, J. M., Garcia-Carbonero, R.

“…Colorectal cancer (CRC) is the second leading cause of cancer dead in Spain. About half the patients will eventually develop distant metastases. However, as…”
Get full text

Ultra-selection of metastatic colorectal cancer patients using next generation sequencing platform to improve clinical efficacy of anti-EGFR therapy by Vidal, J., Dalmeses, A., Vivas, C. Santos, Garcia-Carbonero, R., García-Alfonso, P., Carrato, A., Elez, E., Ortiz, M., Losa, F., Massutí, B., Valladares-Ayerbes, M., Manzano, J., de Prado, J. Vieitez, Gallego, J., Grávalos, C., Varela, M., Azuara, D., Tabernero, J., Salazar, R., Aranda, E., Bellosillo, B., Montagut, C.

Get full text

On measure expansive diffeomorphisms by PACIFICO, M. J., VIEITEZ, J. L.

“…-approximated by non-measure expansive diffeomorphisms.]]>…”
Get full text

Evaluation of the Association Metformin: Plantago ovata Husk in Diabetic Rabbits by Fernández-Martínez, Nélida, Sahagún, Ana M., Sierra, Matilde, Diez, M. José, García, Juan J., Díez, Raquel, Calle, Ángela P.

“…In this experimental study we have investigated whether the inclusion of the dietary fiber Plantago ovata husk could be recommended as coadjuvant in treatments…”
Get full text

Concordance of blood- and tumor-based detection of RAS mutations to guide anti-EGFR therapy in metastatic colorectal cancer by Grasselli, J., Elez, E., Caratù, G., Matito, J., Santos, C., Macarulla, T., Vidal, J., Garcia, M., Viéitez, J.M., Paéz, D., Falcó, E., Lopez Lopez, C., Aranda, E., Jones, F., Sikri, V., Nuciforo, P., Fasani, R., Tabernero, J., Montagut, C., Azuara, D., Dienstmann, R., Salazar, R., Vivancos, A.

“…Circulating tumor DNA (ctDNA) is a potential source for tumor genome analysis. We explored the concordance between the mutational status of RAS in tumor tissue…”
Get full text

Pharmacokinetic behavior of doxycycline after intramuscular injection in sheep by Castro Robles, Luis J, Sahagún Prieto, Ana M, Diez Liébana, M. Jose, Fernández Martínez, Nelida, Sierra Vega, Matilde, García Vieitez, Juan J

“…Objective: To determine the pharmacokinetics of a commercial formulation of doxycycline hyclate after IM administration of a single dose to sheep. Animals: 11…”
Get full text

P17.35 GEINO-10: A PROSPECTIVE OBSERVATIONAL MULTICENTER STUDY OF THE CHARACTERISTICS OF PATIENTS WITH INTRA-AXIAL BRAIN TUMOURS AND THEIR THERAPEUTIC MANAGEMENT IN SPANISH HOSPITALS by Gil-Gil, M. J., Sepulveda, J. M., Vieitez, J. M., Penas, R. d. l., Fernandez-Perez, I., Perez-Segura, P., Fuster, P., Martinez-Garcia, M., Quintanar, T., del Barco, S.

“…INTRODUCTION: Primitive brain tumours (BT) represent 2% of adult malignancies. BT patients are treated by different clinical specialists in Spanish hospitals…”
Get full text

Prospective randomised phase II study of docetaxel versus paclitaxel administered weekly in patients with non-small-cell lung cancer previously treated with platinum-based chemotherapy by Esteban, E., González de Sande, L., Fernández, Y., Corral, N., Fra, J, Muñiz, I., Vieitez, J. M., Palacio, I., Fernández, J. L., Estrada, E., Lacave, A. J.

“…Background: Docetaxel and paclitaxel have activity in the second-line treatment of non-small-cell lung cancer (NSCLC), and can be administered as weekly…”
Get full text

Dietary fiber and its interaction with drugs by González Canga, A, Fernández Martínez, N, Sahagún Prieto, A M, García Vieitez, J J, Díez Liébana, M J, Díez Láiz, R, Sierra Vega, M

“…As the intake of purified dietary fibers is increasing in the society, it is necessary to know how these fibers interact with simultaneously administered…”
Get full text

Tissue distribution of enrofloxacin after intramammary or simulated systemic administration in isolated perfused sheep udders by López Cadenas, Cristina, Fernández Martínez, Nelida, Sierra Vega, Matilde, Diez Liébana, Maria J, Gonzalo Orden, Jose M, Sahagún Prieto, Ana M, García Vieitez, Juan J

“…Objective: To determine the tissue distribution of enrofloxacin after intramammary or simulated systemic administration in isolated perfused sheep udders by…”
Get full text

First-line single-agent regorafenib in frail patients with metastatic colorectal cancer: a pilot phase II study of the Spanish Cooperative Group for the Treatment of Digestive Tumours (TTD) by Carrato, A, Benavides, M, Massutí, B, Ferreiro-Monteagudo, R, García Alfonso, P, Falcó, E, Reboredo, M, Cano, T, Gallego, J, Viéitez, J M, Layos, L, Salud, A, Polo, E, Dotor, E, Durán-Ogalla, G, Rodriguez-Garrote, M, Calvo, A, Grande, E, Aranda, E

“…Treatment of frail patients with advanced colorectal cancer (CRC) is controversial. This pilot phase II trial aimed to assess the efficacy and safety of…”
Get full text

Phase II study of high-sensitivity genotyping of KRAS, NRAS, BRAF and PIK3CA to ultra-select metastatic colorectal cancer patients for panitumumab plus FOLFIRI: the ULTRA trial by Santos, C., Azuara, D., Viéitez, J.M., Páez, D., Falcó, E., Élez, E., López-López, C., Valladares, M., Robles-Díaz, L., García-Alfonso, P., Bugés, C., Durán, G., Salud, A., Navarro, V., Capellá, G., Aranda, E., Salazar, R.

“…Several studies show the importance of accurately quantifying not only KRAS and other low-abundant mutations because benefits of anti-EGFR therapies may depend…”
Get full text

Ultra-selection of metastatic colorectal cancer patients using next-generation sequencing to improve clinical efficacy of anti-EGFR therapy by Vidal, J., Bellosillo, B., Santos Vivas, C., García-Alfonso, P., Carrato, A., Cano, M.T., García-Carbonero, R., Élez, E., Losa, F., Massutí, B., Valladares-Ayerbes, M., Viéitez, J.M., Manzano, J.L., Azuara, D., Gallego, J., Pairet, S., Capellá, G., Salazar, R., Tabernero, J., Aranda, E., Montagut, C.

“…Extended RAS analysis is mandatory in metastatic colorectal cancer (mCRC) patients. The optimal threshold of RAS mutated subclones to identify patients most…”
Get full text